Merck, Baiji and Cornerstone jointly launched an accurate diagnosis and treatment ecosystem aimed at rare targets of lung cancer.

[Merck, Baiji, Cornerstone jointly launched accurate diagnosis and treatment ecosystem aimed at rare targets of lung cancer] FAP, well-known multinational pharmaceutical company Merck, together with Baiji Shenzhou and Cornerstone Pharmaceutical, announced in Shanghai that they will work together to build an accurate diagnosis and treatment ecosystem for lung cancer, looking forward to fully integrating the advantages of all parties to focus on the needs of doctors and patients in the accurate treatment of lung cancer in China, especially the rare / rare targets of lung cancer. Jointly promote the high-quality development of the industry.